Xellar Biosystems
PrivateLast Round
Series A
Jun 29, 2026
Total Funding Raised
$60M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Xellar Biosystems is a biotechnology company that provides an artificial intelligence and organ-on-a-chip platform to accelerate drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Biotech Equipment, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xellar Biosystems Comparables
Compare Xellar Biosystems with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quris AI | 87% | |
| Anivance AI | 84% | |
| Tissue Dynamics | 83% |
Xellar Biosystems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 29, 2026 | ||||
| Strategic | Apr 30, 2025 | ||||
| VC Round | Jul 17, 2024 | ||||
| Angel | Aug 30, 2022 |
Xellar Biosystems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| China Life Investment Management Company | Series A |
| ZhenFund | Angel |
| Zhengxuan Investment | VC Round |
| Tiantu Capital | Strategic, VC Round, Series A |
| Legend Capital | VC Round, Series A, Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 29, 2026
$50M round completed.
- Apr 30, 2025
Led by XtalPi with participation from Tiantu Capital.
Xellar Biosystems Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Xellar Biosystems's valuation, stock price, and market status.
Is Xellar Biosystems a public or private company?
Xellar Biosystems is a private company.
What is the current stock price of Xellar Biosystems?
Xellar Biosystems is a private company, so its shares have no public market price. Caplight tracks Xellar Biosystems's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Xellar Biosystems worth (valuation)?
Valuation information for Xellar Biosystems is not publicly available.
Can I buy Xellar Biosystems stock?
Xellar Biosystems shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Xellar Biosystems's last funding round?
Xellar Biosystems's most recent funding round was Series A on June 29, 2026.
Who are the main investors in Xellar Biosystems?
Key investors in Xellar Biosystems include China Life Investment Management Company, Legend Capital.
Will Xellar Biosystems IPO soon?
No public IPO plans have been announced for Xellar Biosystems.
How can I track Xellar Biosystems secondary market activity?
Caplight tracks bids, offers, and trades in Xellar Biosystems's shares on secondary markets.